Neurodegenerative Diseases: pathogenic mechanisms
Group leaders
Manuel Guzmán Pastor
Ismael Galve Roperh
Tlf. 0034 91 394 46 68
Principal Investigator
- Javier Palazuelos Diego
Collaborating Staff
- Cristina Blázquez Ortiz
- Eva Resel Mariné
- Carlos Costas Insúa
- Tania Aguado Sánchez
- Samuel Simón Sánchez
- Alicia Álvaro Blázquez
- Tánia Gavaldá Vives
- Alba Hermoso López
Group leaders
Manuel Guzmán Pastor
Ismael Galve Roperh
Tlf. 0034 91 394 46 68
Principal Investigator
- Javier Palazuelos Diego
Collaborating Staff
- Cristina Blázquez Ortiz
- Eva Resel Mariné
- Carlos Costas Insúa
- Tania Aguado Sánchez
- Samuel Simón Sánchez
- Alicia Álvaro Blázquez
- Tánia Gavaldá Vives
- Alba Hermoso López
STRATEGIC OBJECTIVES
The overall objective of our research is the study of the molecular mechanisms whereby the cannabinoid receptors act in the brain, as well as the validity of these receptors as therapeutic targets in neurodegeneration, neuro-repair and neuro-oncology. Our work enables the characterisation of new mechanisms of action and cannabinoid receptor-mediated effects, and the identification of new physiopathological implications derived therein.
RESEARCH LINES
- Neurogenesis and neuro-repair by cannabinoid receptors.
- Neuroprotection by cannabinoid receptors.
Location
Madrid Complutense University
Faculty of Biological Sciences
Annex Building
Department of Molecular Biochemistry and Biology
Calle José Antonio Novais, 12
28040 Madrid
+34 91 394 46 68
Keywords
neurodegeneration, neurogenesis, neuro-repair, neuropharmacology, cannabinoid